Sotac Pharmaceuticals Limited IPO Date, Price, Review and Details
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelSotac Pharmaceuticals Limited IPO
March 29, 2023 - April 03, 2023
Closed
Sotac Pharmaceuticals Limited IPO
This Company was incorporated in 2015 and was engaged in manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. Their business is majorly on a principal basis with other marketers. Sotac group is the pharma manufacturer specializing in the manufacturing of the wide range of pharmaceutical products. Their Company has marked its presence in both domestic as well as offshore markets.
Their Strengths are a Wide range of products, Experienced Promoters and Management Team, a Scalable Business Model, and Quality assurance.
Company Promoters:
• Mr. Sharadkumar Dashrathbhai Patel
• Mr. Dineshkumar Babulal Gelot
• Mr. Vishalkumar Devrajbhai Patel
• Mr. Chetankumar Bachubhai Patel
• Mrs. Kiran Baldevbhai Jotania
Objects of this Issue:
• To Meet Working Capital Requirements
• Investment in Subsidiary
• Upgradation / Construction of Existing /New Building in the Existing Premises
• General Corporate Purpose
• To meet Public Issue Expenses
Financial Information of the Company:
Particulars | Amount in Lakhs (Rs.) | ||
As on 31 Mar 2022 | As on 31 Mar 2021 | As on 31 Mar 2020 | |
Total Assets | 3,525.35 | 3,469.75 | 3,038.21 |
Total Liabilities | 2,863.16 | 3,220.39 | 2,732.47 |
Net Profit | 287.86 | -236.54 | 8.75 |
Sotac Pharmaceuticals Limited IPO Schedule
1. Bid or Offer Opens on: 29 March 2023
2. Bid or Offer Closes on: 03 April 2023
3. Finalization of BoA: 10 April 2023
4. Initiation of Refunds: 11 April 2023
5. Credit of shares to Demat account: 12 April 2023
6. Listing Date: 13 April 2023
Sotac Pharmaceuticals Limited IPO Lot Size
The market lot size of the Sotac Pharmaceuticals Limited IPO is 2,400 shares. The minimum and maximum order quantity is as follows:
Application | Lots | Shares | Amount |
Minimum | 1 | 1200 | ₹133,200 |
Maximum | 1 | 1200 | ₹133,200 |
S-HNI(Minimum) | 2 | 2,400 | ₹266,400 |
Company Contact Details:
Plot No. PF-21, Nr. ACME Pharma, Opp. Teva
Pharma Sanand GIDC-II, Sanand Ahmedabad -
382110, Gujarat, India
Phone: +91 90819 93300
Email: compliance@sotacpharma.com
Website: http://www.sotacpharma.com/
Sotac Pharmaceuticals Limited IPO Registrar Details:
KFin Technologies Limited
Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda,
Serilingampally, Hyderabad – 500 032, Telangana, India.
Telephone: 04067162222, 04079611000
Email: sotac.ipo@kfintech.com
Website: https://karisma.kfintech.com/
Frequently Asked Question
Sotac Pharmaceuticals Limited IPO shares will get listed on April 13, 2023.
Minimum and maximum order quantity is 1 lot only.
If you do not get the allotment of Sotac Pharmaceuticals Limited IPO shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Per share price of Sotac Pharmaceuticals Limited IPO is ₹105 to ₹111 per share.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in SVS Limited IPO using any neatest method at your convenience.
Opening date of Sotac Pharmaceuticals Limited IPO is March 29, 2023.
If allotted, you will receive Sotac Pharmaceuticals Limited IPO shares in your Demat account on April 12, 2023.
Lot size of the Sotac Pharmaceuticals Limited IPO is 1200 shares.
Face value of Sotac Pharmaceuticals Limited IPO is ₹10 per share.
Pre-issue shareholding of the Sotac Pharmaceuticals Limited IPO promoter is 84.63%.
Sotac Pharmaceuticals Limited IPO Shares will get listed at NSE SME.
Closing date of Sotac Pharmaceuticals Limited IPO is April 03, 2023.
Comments for Sotac Pharmaceuticals Limited IPO Date, Price, Review and Details
0 comments